questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Sarcoïdose
Sarcoïdose pulmonaire
Sarcoïdose pulmonaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Sarcoïdose
Diagnostic médical
Tests sanguins
Inflammation
Radiologie
Infiltrats pulmonaires
Biopsie
Diagnostic différentiel
Symptômes
5
Variabilité des symptômes
Sarcoïdose
Prévention
5
Facteurs environnementaux
Irritants
Traitements
5
Corticostéroïdes
Traitement
Immunosuppresseurs
Traitement alternatif
Surveillance
Fonction pulmonaire
Effets secondaires
Corticostéroïdes
Complications
5
Fibrose pulmonaire
Complications
Suivi médical
Prévention des complications
Réversibilité
Complications
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Sarcoïdose
Exposition professionnelle
Facteurs de risque
Antécédents familiaux
Sarcoïdose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire : Questions médicales les plus fréquentes",
"headline": "Sarcoïdose pulmonaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sarcoïdose pulmonaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert P Baughman",
"url": "https://questionsmedicales.fr/author/Robert%20P%20Baughman",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio."
}
},
{
"@type": "Person",
"name": "Dominique Valeyre",
"url": "https://questionsmedicales.fr/author/Dominique%20Valeyre",
"affiliation": {
"@type": "Organization",
"name": "Service de Pneumologie, INSERM UMR 1272, Université Sorbonne Paris Nord, AP-HP Hopital Avicenne, Bobigny, France."
}
},
{
"@type": "Person",
"name": "Jan C Grutters",
"url": "https://questionsmedicales.fr/author/Jan%20C%20Grutters",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands."
}
},
{
"@type": "Person",
"name": "Rohit Gupta",
"url": "https://questionsmedicales.fr/author/Rohit%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hilario Nunes",
"url": "https://questionsmedicales.fr/author/Hilario%20Nunes",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France. Electronic address: hilario.nunes@aphp.fr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Antimicrobial resistance in topical treatments for microbial keratitis: protocol for a systematic review and meta-analysis.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36882242",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-069338"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37665358",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00403-023-02688-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis.",
"datePublished": "2024-10-18",
"url": "https://questionsmedicales.fr/article/39425031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-024-02356-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.",
"datePublished": "2022-09-02",
"url": "https://questionsmedicales.fr/article/36691161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-063884"
}
},
{
"@type": "ScholarlyArticle",
"name": "How To Read a Network Meta-analysis.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37925328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euf.2023.10.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sarcoïdose",
"item": "https://questionsmedicales.fr/mesh/D012507"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sarcoïdose pulmonaire",
"item": "https://questionsmedicales.fr/mesh/D017565"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sarcoïdose pulmonaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sarcoïdose pulmonaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sarcoïdose pulmonaire",
"description": "Comment diagnostiquer la sarcoïdose pulmonaire ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles ?\nQuelles sont les caractéristiques radiologiques ?\nLa biopsie est-elle toujours nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sarcoïdose pulmonaire",
"description": "Quels sont les symptômes courants ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des symptômes systémiques ?\nLes symptômes varient-ils d'un patient à l'autre ?\nLes symptômes peuvent-ils s'aggraver ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sarcoïdose pulmonaire",
"description": "Peut-on prévenir la sarcoïdose pulmonaire ?\nY a-t-il des facteurs environnementaux à éviter ?\nLe tabagisme influence-t-il la sarcoïdose ?\nDes vaccinations sont-elles recommandées ?\nLe stress a-t-il un impact sur la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sarcoïdose pulmonaire",
"description": "Quels traitements sont disponibles ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils toujours nécessaires ?\nComment surveiller l'efficacité du traitement ?\nLes effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sarcoïdose pulmonaire",
"description": "Quelles sont les complications possibles ?\nLa sarcoïdose peut-elle affecter d'autres organes ?\nComment prévenir les complications ?\nLes complications sont-elles réversibles ?\nQuels sont les signes d'alerte des complications ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sarcoïdose pulmonaire",
"description": "Quels sont les facteurs de risque connus ?\nL'exposition professionnelle est-elle un facteur ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Meta-Analysis+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la sarcoïdose pulmonaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, radiologiques et histologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la biopsie."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent aider à évaluer l'inflammation et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quelles sont les caractéristiques radiologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe souvent des adénopathies hilaires et des infiltrats pulmonaires."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais elle est souvent essentielle pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux, l'essoufflement et la douleur thoracique."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente et peut être sévère chez les patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre et la perte de poids peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent s'aggraver avec le temps ou lors de poussées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sarcoïdose pulmonaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention connue pour la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des agents irritants ou allergènes peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la sarcoïdose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les symptômes et la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Des vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune vaccination spécifique n'est recommandée pour prévenir la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la maladie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, mais il ne cause pas la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes sont le traitement principal pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des immunosuppresseurs peuvent être utilisés si les corticostéroïdes sont inefficaces."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils toujours nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains patients peuvent ne pas nécessiter de traitement actif."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens cliniques et des tests de fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pulmonaire et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "La sarcoïdose peut-elle affecter d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les yeux, la peau, et le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une aggravation de l'essoufflement ou de la douleur thoracique doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et l'origine ethnique afro-américaine."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des agents susceptibles de déclencher la maladie."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de sarcoïdose peut augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer la sarcoïdose que les hommes."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la sarcoïdose est plus fréquente chez les adultes jeunes et d'âge moyen."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio.
6 publications dans cette catégorie
Affiliations :
Service de Pneumologie, INSERM UMR 1272, Université Sorbonne Paris Nord, AP-HP Hopital Avicenne, Bobigny, France.
6 publications dans cette catégorie
Affiliations :
Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Department of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands.
5 publications dans cette catégorie
Affiliations :
Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
Publications dans "Sarcoïdose pulmonaire" :
5 publications dans cette catégorie
Affiliations :
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France. Electronic address: hilario.nunes@aphp.fr.
Publications dans "Sarcoïdose pulmonaire" :
4 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY 12208, USA.
Publications dans "Sarcoïdose pulmonaire" :
4 publications dans cette catégorie
Affiliations :
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France.
Publications dans "Sarcoïdose pulmonaire" :
4 publications dans cette catégorie
Affiliations :
Cleveland Clinic, Cleveland, OH. Electronic address: culverd@ccf.org.
Publications dans "Sarcoïdose pulmonaire" :
3 publications dans cette catégorie
Affiliations :
INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France.
Publications dans "Sarcoïdose pulmonaire" :
3 publications dans cette catégorie
Affiliations :
Lewis Katz School of Medicine, Department of Thoracic Medicine and Surgery, Philadelphia, PA, USA. Electronic address: jinsun.kim@tuhs.temple.edu.
Publications dans "Sarcoïdose pulmonaire" :
3 publications dans cette catégorie
Affiliations :
Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Publications dans "Sarcoïdose pulmonaire" :
3 publications dans cette catégorie
Affiliations :
Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Publications dans "Sarcoïdose pulmonaire" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Miami, FL, USA.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Research Unit, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France; AP-HP, Radiology Department, Avicenne Hospital, Bobigny, 93009, France.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France; AP-HP, Physiology Department, Avicenne Hospital, Bobigny, 93009, France.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France; AP-HP, Department of Respiratory and Intensive CareMedicine, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
a Interstitial Lung Disease Program, Servei de Pneumologia, ICR, Hospital Clínic, Barcelona.- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , University of Barcelona , Barcelona , Spain.
e Centro de Investigaciones biomedicas En Red-Enfermedades Respiratorias (CibeRes CB06/06/0028)-ISCIII , Barcelona , Spain.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
Service de Radiologie, Hôpital Avicenne, 93009 Bobigny, France.
Publications dans "Sarcoïdose pulmonaire" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Publications dans "Sarcoïdose pulmonaire" :
There is evidence for increased resistance against the antimicrobials used to treat keratitis. This review aims to provide global and regional prevalence estimates of antimicrobial resistance in corne...
We report this protocol following Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols guidelines. We will conduct an electronic bibliographic search in MEDLINE, EMBASE, Web of ...
Ethics approval is not required as this is a protocol for a systematic review of published data. The findings of this review will be published in an open-access, peer-reviewed journal....
CRD42023331126....
Androgenetic alopecia is a widespread condition that is the most common type of hair loss affecting approximately 58% and 40% of men and women by the age of 50, respectively. Patients have been known ...
Systematic review with meta-analysis integrates findings from multiple studies, offering robust conclusions on treatment effects and guiding evidence-based medicine. However, the process is often hamp...
Meta-Analysis Accelerator was developed to address these challenges. The tool offers 21 different statistical conversions, including median & interquartile range (IQR) to mean & standard deviation (SD...
Since its initial release in October 2023 as Meta Converter and subsequent renaming to Meta-Analysis Accelerator, the tool has gained widespread use globally. From March 2024 to May 2024, it received ...
Meta-Analysis Accelerator significantly enhances the efficiency and accuracy of meta-analysis of systematic reviews by providing a reliable platform for statistical data conversion. Its comprehensive ...
Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and ac...
We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous t...
No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field....
CRD42021226034....
Network meta-analysis (NMA) expands upon traditional meta-analysis by integrating three or more interventions. This allows comparing interventions using evidence from trials that have compared pairs o...
Collaborative care interventions have been proposed as a promising strategy to support patients with multimorbidity. Despite this, the effectiveness of collaborative care interventions requires furthe...
This systematic review aims to systematically assess the effectiveness of collaborative care interventions in comparison to usual care concerning health-related quality of life (HRQoL), mental health,...
Randomized controlled trials evaluating collaborative care interventions designed for adult patients (18 years and older) with multimorbidity compared with usual care will be considered for inclusion ...
The preliminary literature search was performed on February 16, 2024, and yielded 5255 unique records. A follow-up search will be performed across all databases before submission. The findings will be...
This review will provide an overview of pooled estimates of treatment effects across HRQoL, mental health, and mortality from randomized controlled trials evaluating collaborative care interventions f...
International Prospective Register of Systematic Reviews (PROSPERO) CRD42024512554; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=512554....
DERR1-10.2196/58296....
Meta-analyses constitute fundamental tools of the Evidence-Based Medicine (EBM) aiming at synthesizing outcome data from individual trials in order to produce pooled effect estimates for various outco...
Bayesian methods seem a natural choice for combining sources of evidence in meta-analyses. However, in practice, their sensitivity to the choice of prior distribution is much less attractive, particul...
Diagnostic evidence of the accuracy of a test for identifying a target condition of interest can be estimated using systematic approaches following standardized methodologies. Statistical methods for ...
In this article, we present the updated version, Meta-DiSc 2.0, a web-based application developed using the R Shiny package. This new version implements recommended state-of-the-art statistical models...
We have developed and validated an updated version of the Meta-DiSc software that is more accessible and statistically sound. The web application is freely available at www.metadisc.es ....
Topical non-steroidal anti-inflammatory drugs have the potential to reduce treatment burden and improve outcomes of anti-VEGF therapy for a number of retinal disorders, including neovascular age-relat...
Cochrane Library, PubMed, and EMBASE were systematically reviewed to identify the relevant studies of neovascular age-related macular degeneration, diabetic macular edema, macular edema associated wit...
In total, ten studies evaluating bromfenac as an adjunct to anti-VEGF therapy were identified. Five studies were included in meta-analysis of the number of injections and five studies were included in...
This literature review and meta-analysis showed that topical bromfenac can be considered as a safe adjunct to anti-VEGF therapy with a potential to reduce the treatment burden with anti-VEGF drugs req...